Skip to content
Home/GPs/CBPE Capital
DetailCard
CBPE Capital

CBPE Capital

London, United Kingdom·Founded 1984··cbpe.com

CBPE Capital LLP is a London-based lower and mid-market private equity firm founded in 1984 as Close Brothers Private Equity, becoming independent through a management buyout in 2008. It invests in primary buyouts of UK and Ireland companies with enterprise values of around GBP 25 million to GBP 150 million across business services, healthcare, technology, financial services, industrials and consumer sectors. CBPE closed its latest fund, CBPE Fund XI, at its GBP 714 million hard cap in March 2025, following Fund X (GBP 561 million, 2020) and Fund IX (GBP 459 million, 2016). The firm is authorised and regulated by the UK Financial Conduct Authority under firm reference number 229900.

AUM
€1.7B
Funds
3
vintages 2016–2025
Portfolio
13
Exits
7

CBPE Capital is a London buyout firm with €1.7B AUM, 13 active companies and 7 exits.

Key takeaways
  • ·7 exits in the last 5 years · consistent DPI cadence.
  • ·Average hold across 7 realized deals: 6 years.
  • ·Best return: 10.8x MOIC on Xceptor (2021).
  • ·Fund cadence: ~5Y between vintages · last raise 2025.

Sector breakdown

20 companies
Business Services
4 · 20%
Healthcare
4 · 20%
IT Services
2 · 10%
Financials
2 · 10%
Industrials
2 · 10%
HealthTech
1 · 5%
Consumer
1 · 5%
LegalTech
1 · 5%

Geography breakdown

4 geographies
UK
17 · 85%
Ireland
1 · 5%
Luxembourg
1 · 5%
Germany
1 · 5%

Key facts

HQLondon, United Kingdom
Founded1984
Employees29+
Websitecbpe.com

Recent exits

Simbec-Orion

CBPE Capital sold Simbec-Orion to Caidya in 2026 after 7 years.

The Key Group

CBPE Capital sold The Key Group to Permira in 2025 after 5 years.

Centralis

CBPE Capital sold Centralis to HGGC in 2025 after 5 years.

5.3x

CBPE Capital sold Perspective Financial Group to Charlesbank Capital Partners in 2024 after 5 years.

5.4x

Partners

Ian MooreManaging Partner
Anand JainPartner
Mathew HutchinsonPartner
Jolyon LatimerPartner

Coverage notes

3 funds tracked, 20 portfolio companies (13 active · 7 realized). Verified weekly from public filings and deal announcements.

Investment team

Senior partners. Hand-checked from public filings and the firm's own site.

Ian Moore
Managing Partner
Anand Jain
Partner
Mathew Hutchinson
Partner
Jolyon Latimer
Partner

Funds & portfolio

Every fund CBPE Capital has raised, with its portfolio companies. Hand-checked from public filings.

3 funds
CBPE Fund XI
Buyout2025€835M4 assets

Unrealized

4 held
CompanyEntry
Access Infinity
HealthTech · UK
2026
Brookbanks Consulting
Business Services · UK
2026
Tetra Consulting
Business Services · UK
2025
Velociti Solutions
IT Services · UK
2025
CBPE Capital Fund X
Buyout2020€656M8 assets1 exits

Unrealized

8 held
CompanyEntry
Banner
Consumer · UK
2021
Clifton Asset Management
Financials · UK
2024
HealthNet Homecare
Healthcare · UK
2024
HF
LegalTech · UK
2025
HGF
Business Services · UK
2024
Snigel
AdTech · Ireland
2023
TREND Networks
Industrials · UK
2018
Veincentre
Healthcare · UK
2022

Realized

1 exit
CompanyEntryExitTypeBuyerMOIC
The Key Group
IT Services · UK
20202025SecondaryPermira–
CBPE Capital Fund IX
Buyout2016€537M1 assets6 exits

Unrealized

1 held
CompanyEntry
Blatchford
MedTech · UK
2018

Realized

6 exits
CompanyEntryExitTypeBuyerMOIC
Centralis
Business Services · Luxembourg
20202025SecondaryHGGC5.3x
Perspective Financial Group
Financials · UK
20192024SecondaryCharlesbank Capital Partners5.4x
Rodericks Dental
Healthcare · UK
20172022SecondaryCapVest–
Safechem
Industrials · Germany
20162024Trade SaleItelyum–
Simbec-Orion
Healthcare · UK
20192026Trade SaleCaidya–
Xceptor
Fintech · UK
20172021SecondaryAstorg10.8x

About CBPE Capital

CBPE Capital is a UK and Ireland mid-market private equity firm with approximately £1.6 billion of assets under management as of December 2024 (with Fund XI closing at £714 million hard cap in 2025), headquartered in London. The firm was founded in 1984 as Close Brothers Private Equity before becoming an independent buyout in 2009. CBPE remains a partner-owned independent LLP with a 40 plus year continuous UK mid-cap buyout franchise.

Investment thesis

CBPE deploys capital through 11 active fund vintages (Fund X 2021, Fund XI closed April 2025 at £714 million), targeting UK and Ireland primary buyouts in cash-generative growth companies with enterprise values up to £175 million. Sector focus spans business services, healthcare and pharmaceuticals, financial services, technology, industrials and consumer and leisure, with geographic deployment concentrated on UK and Ireland mid-market opportunities. The primary-buyout discipline combined with high mid-cap repeat-conversion track record reflects the platform's long-tenured team and disciplined sourcing approach.

Recent activity

Recent realised exits include healthcare and CRO (2024), corporate services and admin (February 2025) and education services (November 2025). Recent acquisitions include Clifton Asset Management (financial services, October 2024), Tetra Consulting (March 2025) and Access Infinity (February 2026). The platform continues active deployment of Fund XI.

Frequently asked questions

What investment strategy does CBPE Capital focus on?
CBPE Capital focuses on Buyout, Growth strategies in the private equity space.
How many portfolio companies does CBPE Capital have?
CBPE Capital has 13 active portfolio companies and 7 completed exits and 3 funds tracked on GP Intel.
Where is CBPE Capital headquartered?
CBPE Capital is headquartered in London, United Kingdom.
What is CBPE Capital's assets under management?
CBPE Capital manages approximately €1.7B in assets under management.
When was CBPE Capital founded?
CBPE Capital was founded in 1984.
What sectors does CBPE Capital invest in?
CBPE Capital invests across Business Services, Healthcare, TMT, Financials, Industrials, Consumer.
What are CBPE Capital's recent exits?
Recent realized exits by CBPE Capital include: Simbec-Orion (2026) to Caidya; The Key Group (2025) to Permira; Centralis (2025) to HGGC, 5.3x; Perspective Financial Group (2024) to Charlesbank Capital Partners, 5.4x; SAFECHEM (2024) to Itelyum; Rodericks Dental (2022) to CapVest; Xceptor (2021) to Astorg, 10.8x.
Look up another firm or company
Last updated August 2026 · Sourced from public filings · Report an issue